Dr. Harvey graduated from the Ross Univ, Sch of Med, Roseau, Dominica in 1989. He works in Carson, CA and specializes in Family Medicine. Dr. Harvey is affiliated with Providence Little Company Of Mary Medical Center San Pedro and Torrance Memorial Medical Center.
Strayer University Raleigh, NC 2014 to 2015 Bachelors Degree in Business ManagementIndian River State College Fort Pierce, FL 2004 to 2006 Associates Degree in Business Management
Us Patents
Pyridylpiperazines And Aminonicotinamides And Their Use As Therapeutic Agents
Michael D. Winther - Vancouver, CA Richard M. Fine - Ridgewood NJ, US Boris Klebansky - Demarest NJ, US Heinz Gschwend - Santa Rosa CA, US Daniel F. Harvey - San Diego CA, US
Assignee:
Xenon Pharmaceuticals Inc. - Burnaby, BC
International Classification:
A61K 31/495 C07D 401/04
US Classification:
514255, 544360
Abstract:
Novel compounds useful in the treatment of, prevention of or protection against diseases and/or conditions related to metabolic syndrome and lipid metabolism, especially diseases of fatty acid and cholesterol metabolism, such as those mediated by stearoyl-CoA desaturase, are disclosed along with methods of employing said compounds for such uses.
Nicotinamide Derivatives And Their Use As Therapeutic Agents
Jian-Min Fu - Burnaby, CA Vishnumurthy Kodumuru - Burnaby, CA Shaoyi Sun - Vancouver, CA Michael Winther - Vancouver, CA Richard Fine - Ridgewood NJ, US Daniel Harvey - San Diego CA, US Boris Klebansky - Demarest NJ, US Heinz Gschwend - Santa Rosa CA, US Wenbao Li - San Diego CA, US
International Classification:
A61K031/551 A61K031/496
US Classification:
514218000, 514253090, 514253110
Abstract:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
Nicotinamide Derivatives And Their Use As Therapeutic Agents
Jian-Min Fu - Coquitlam, CA Vishnumurthy Kodumuru - Burnaby, CA Shaoyi Sun - Coquitlam, CA Michael D. Winther - Vancouver, CA Richard M. Fine - Ridgewood NJ, US Daniel F. Harvey - San Diego CA, US Boris Klebansky - Demarest NJ, US Heinz W. Gschwend - Santa Rosa CA, US Wenbao Li - San Diego CA, US
Assignee:
XENON PHARMACEUTICALS INC. - Burnaby
International Classification:
A61K 31/496 C07D 401/04 A61P 3/10
US Classification:
51425313, 544365
Abstract:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I):where m, n, p, V, R, R, R, R, Rand Rare defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.